key: cord-0798240-99yxdqpy authors: Kim, Hyo-Jung; Park, JaeHan; Kim, Ji-Soo title: Update on benign paroxysmal positional vertigo date: 2020-11-24 journal: J Neurol DOI: 10.1007/s00415-020-10314-7 sha: 82fa69a5508031ff3505d79bd0556c40b81f26bc doc_id: 798240 cord_uid: 99yxdqpy Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo worldwide. This review considers recent advances in the diagnosis and management of BPPV including the use of web-based technology and artificial intelligence as well as the evidence supporting the use of vitamin D supplements for patients with BPPV and subnormal serum vitamin D. Benign paroxysmal positional vertigo (BPPV) is characterized by paroxysms of vertigo triggered by head position changes in the direction of gravity [1] . BPPV is explained by migration of degenerated otoconia into the semicircular canals, rendering them sensitive to head motion [2] . BPPV is the most common cause of dizziness/vertigo worldwide with a lifetime prevalence of 2.4%, a 1-year prevalence of 1.6%, and 1-year incidence of 0.6% [3] . BPPV accounts for 24.1% of all hospital visits due to dizziness/vertigo [4] . BPPV is most common in elderly women with a peak incidence in their sixties and a women-to-men ratio of 2 [9] . Therefore, the healthcare burden due to BPPV totals around 2 billion US$ in the USA per year [15] and is likely to increase as the population ages. According to data from South Korea, the number of hospital visits per 100,000 of general population due to dizziness and vertigo was around 3974 in 2019 and could increase to 6057 by 2050, which corresponds to an increase of 52% [4]. The cause of BPPV is mostly unknown although cases may be associated with head trauma, a prolonged recumbent position, or various disorders involving the inner ear [16] . Other risk factors for BPPV may include female gender, age under 65 years, a high income, living in a metropolis, osteoporosis, hypertension, and non-apnea sleep disorders [17] [18] [19] [20] . Indeed, a recent meta-analysis found that female gender, hypertension, diabetes mellitus, hyperlipidemia, osteoporosis, and vitamin D deficiency are risk factors for recurrences of BPPV [19] . Linked to this is the finding that elderly women with a lack of physical activity have a 2.6 times higher risk for BPPV than those who undertake regular activity [21] . Furthermore, vitamin D deficiency (< 10 ng/ ml) and insufficiency (10-20 ng/ml) have been associated with BPPV with an odds ratios of 3.8 and 23.0 [22] . This has obvious therapeutic implications (see below). In the western countries, the posterior canal (PC) has been known to be the most commonly involved (88-90%) in BPPV with a predilection for the right ear [23, 24] . In studies conducted in South Korea, however, involvement of other semicircular canals (not just the PC) has been shown to be more common than previously reported in western countries [25] . Even though the PC was most commonly involved (59-61%), BPPV of the non-pure PC-BPPV type comprises about 40% of total BPPV, especially with involvement of the horizontal canal (HC-BPPV), where the otolithic debris may be located either in the canal (canalolithiatic or geotropic, 61-66%) or attached to the cupula (cupulolithiatic or apogeotropic, 31-33%) [10, 21] . The causes for this discrepancy is unknown [25]. The International Classification of Vestibular Disorders (ICVD) formulated by the Barany Society established the diagnostic criteria for BPPV [26] , which include recurrent attacks of positional vertigo/dizziness provoked by position changes, and the characteristic positional nystagmus elicited by each positional maneuver according to the subtype and affected ear [26] . During the Dix-Hallpike maneuver for diagnosis of PC-BPPV, a pillow may be placed under the shoulders instead of extending the patient's neck about 30° below the table [27] . This modified maneuver may be useful in the limited clinical setting or in patients with a limited range of motion or difficulty relaxing their neck. HC-BPPV is diagnosed by determining the direction and relative intensity of the horizontal nystagmus induced during head-turning while supine. In both the canalolithiatic (geotropic) and cupulolithiatic (apogeotropic) types of HC-BPPV, the nystagmus beating to the lesion side is greater than that to the healthy side [1]. The accuracy of bedside lateralization of the affected side is acceptable in HC-BPPV when the nystagmus asymmetry is more than 30% [28] . When the intensities of nystagmus triggered during supine head-rolling test are similar between the directions, the direction of nystagmus induced by lying down or head bending (bow and lean test) may aid in lateralization of the involved side [29, 30] . The lyingdown nystagmus mostly beats away from the affected ear in geotropic HC-BPPV but beats toward the affected ear in the apogeotropic type, while the reverse holds for the head-bending nystagmus [29, 30] . Patients with PC-BPPV may show vertical nystagmus during the bow-and-lean test [31] . A recent study found that head-shaking nystagmus (the nystagmus observed after head oscillation at 2-3 Hz in the horizontal plane for 20 cycles) occurs in about a half of the patients with HC-BPPV in the direction of headbending nystagmus, thus helping lateralize the affected side [32] . The duration of vertigo and nystagmus is typically less than one minute in the canalolithiatic type of HC-BPPV Otolin-1 is an inner ear-specific collagen that forms a scaffold to promote optimal formation of the otoconia. Owing to its potential passage through the labyrinth-blood barrier, otolin-1 can be detected in the peripheral blood and may serve a biomarker for BPPV [19] . Thus, high serum levels of otolin-1 (> 300 pg/ml) may discriminate patients with BPPV from healthy controls [20] . The gold standard for diagnosing and determining the subtype of BPPV is the observation of characteristic nystagmus triggered during the positional maneuvers as mentioned above. However, a few studies have explored the utility of questionnaires in confirming BPPV and determining the subtypes [43-45] based on the characteristics (positional triggering, duration etc.) of the vertigo and positional changes that mostly induce it. [43] . A recent study investigating this questionnaire approach showed an acceptable sensitivity and specificity for the diagnosis of BPPV [45] . The questionnaire is comprised of six questions. The first three are designed to diagnose BPPV, and the latter three to determine the subtype and affected ear. This new approach for self-diagnosis of BPPV using a questionnaire would pave the way for selfadministration of an appropriate canalith repositioning procedure when BPPV occurs and recurs. By virtue of both recent developments in information (IT) and biology (BT) technology through programs available on mobile devices [46] and using artificial intelligence and a deep-learning model, interest has turned to whether this approach can be used to determine the underlying disorder(s) causing dizziness and vertigo, and with this the subtype of BPPV [47] . Furthermore, recording of nystagmus during the attacks of vertigo may also become feasible in near future using various portable devices [48] . These kinds of approaches adopting artificial intelligence, deeplearning, wearable devices, and mobile applications, will become more important in determining the cause of vertigo, especially when we have to rely more on telemedicine as is the case now given the COVID-19 pandemic. BPPV patients show 1-year recurrence rates of approximately 20% and 5-year recurrence rates of approximate. Even though BPPV may resolve spontaneously, canalith repositioning procedure (CRP) has been established as the gold standard for the treatment of BPPV during the attacks [1, [49] [50] [51] . CRPs may result in resolution of symptoms and positional nystagmus in 80% with a single application [52] , and in up to 92% with a repetition [53] . Various CRPs have shown efficacy in randomized controlled trials, and this includes the Epley and Semont maneuvers for PC-BPPV [54, 55] , barbecue rotation and Gufoni's maneuver for geotropic HC-BPPV [56] , and head-shaking and Gufoni's maneuvers for apogeotropic HC-BPPV [57] . For AC-BPPV, several maneuvers including the reversed Epley's [58] and Yacovino's maneuvers [59] may be attempted [60] . A multiaxis positioning chair attached to the video-oculography may be applied for treatment of BPPV [61, 62] . Modified or simplified versions of CRPs have also been proposed [63] . The Gans maneuver has shown long-term efficacy similar to Epley maneuver for PC-BPPV [64] . The efficacy of Li's quick repositioning maneuver was similar to that of the barbecue maneuver for geotropic HC-BPPV [65] . Another maneuver adopted an affected-ear-up 90° position for geotropic HC-BPPV and reported resolution of the symptoms in 83% [66] . These maneuvers, however, require further validation through randomized controlled trials. A recent study established the efficacy of forced prolonged position for HC-BPPV in comparison to a sham maneuver using a double-blind randomized trial [67] . In this study, patients with geotropic HC-BPPV (n = 149) were instructed to stay lying on the healthy side in the treatment group and on the involved side in the sham group (76.9 vs. 11.3%, p < 0.0001), and vice versa in the apogeotropic type (n = 72, 60.5 vs. 17.6%, p = 0.0003) [67] . These CRPs may be attempted by the patients themselves at home. Adding self-treatments at home after the CRPs performed at the office/clinic is more effective than the office/ clinic-based CRPs alone [68, 69] . Some devices have also been developed for an easy and accurate application of the CRPs at home [70, 71] . However, self-application of CRPs requires an accurate identification of the involved canal and subtype of BPPV. For this purpose, a simple questionnaire consisting of six questions, which was mentioned above, was developed and showed an accuracy of 71.2% in diagnosing BPPV and determining the involved canal and type [45] . Furthermore, a clinical trial is under way for self-application of CRPs based on the results of this questionnaire (CRIS registry no. KCT00002364) [45] . Patients with BPPV occasionally suffer from persistent vertigo after CRPs. In these instances, the residual otolithic debris may be located in the distal portion of the PC, and the patients may show positional downbeat nystagmus due to migration of the debris toward the ampulla during the positioning [72] . In this instance, repetition of CRPs may help treat the residual vertigo. Repeat attacks of BPPV are frequent [5, 6] with the recurrences in a half of the patients within 40 months [7, 8] . A recent study found that these recurrences were somewhat random with only 24% of them involving the same canal on the same side as was affected in the previous attack [9]. A role for vitamin D in BPPV has recently been shown to be significant. In a recent randomized clinical trial, patients with BPPV were randomly allocated either to have measurements of serum vitamin D and take 400 IU vitamin D and 500 mg calcium twice a day when the serum vitamin D level was subnormal or to be simply followed-up for the recurrences without intervention. A significant reduction in the recurrences was found in the treatment group (Fig. 1a) [73] . A subsequent meta-analysis of six randomized trials also proved the preventive effect of vitamin D supplementation on recurrences of BPPV (Fig. 1b) [74] . Thus, supplementation of vitamin D should be considered in patients with recurrent BPPV and subnormal serum vitamin D. Otolith dysfunction could be associated with an increase in the recurrences of BPPV [75, 76] . Thus, the vestibular rehabilitation program including may reduce the recurrence rate of BPPV [77] . This program includes jumping on the trampoline-like surface with eyes open and closed, reading a text during linear head movements, standing on the tilt board and using an exercise ball. Even though benign, BPPV brings with it major socio-economic impacts. Being able to better diagnose this, especially using remote devices would be a major breakthrough and ways to do this are being actively explored with encouraging data to support their adoption. In addition, while a range of physical therapies can be successfully used to treat BPPV, there are interesting new data suggesting a role for vitamin D supplementation in a subgroup of patients with low serum levels of this vitamin. Natural course of the remission of vertigo in patients with benign paroxysmal positional vertigo Use of BPPV processes in emergency department dizziness presentations: a population-based study Effectiveness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo: a systematic review Short-term efficacy of Epley's manoeuvre: a double-blind randomised trial Repeated vs single physical maneuver in benign paroxysmal positional vertigo Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Switch to Semont maneuver is no better than repetition of Epley maneuver in treating refractory BPPV Randomized clinical trial for geotropic horizontal canal benign paroxysmal positional vertigo Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo Paroxysmal positional vertigo syndrome New therapeutic maneuver for anterior canal benign paroxysmal positional vertigo Diagnosis and treatment of anterior-canal benign paroxysmal positional vertigo: a systematic review BPPV and variants: improved treatment results with automated, nystagmus-based repositioning Hougaard DD (2020) Treatment of benign paroxysmal positional vertigo with the TRV reposition chair A Chair-based Abbreviated Repositioning Maneuver (ChARM) for fast treatment of posterior BPPV A safe-repositioning maneuver for the management of benign paroxysmal positional vertigo: Gans vs. Epley maneuver; a randomized comparative clinical trial A prospective randomized controlled study of Li quick repositioning maneuver for geotropic horizontal canal BPPV A new treatment (the affected-ear-up 90 degrees maneuver) for benign paroxysmal positional vertigo of the lateral semicircular canal Double-blind randomized trial on the efficacy of the forced prolonged position for treatment of lateral canal benign paroxysmal positional vertigo The efficacy of a home treatment program combined with office-based canalith repositioning procedure for benign paroxysmal positional vertigo-a randomized controlled trial Complementary self-treatment for posterior canal benign paroxysmal positional vertigo Evaluation of a particle repositioning maneuver web-based teaching module Efficacy of a new home treatment device for benign paroxysmal positional vertigo Incidence and clinical significance of positional downbeat nystagmus in posterior canal benign paroxysmal positional vertigo Prevention of benign paroxysmal positional vertigo with vit D supplementation: a randomized trial Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis Otolith dysfunction in recurrent benign paroxysmal positional vertigo after mild traumatic brain injury Otolithic damage study in patients with benign paroxysmal positional vertigo with vestibular evoked myogenic potentials The effects of the vestibular rehabilitation on the benign paroxysmal positional vertigo recurrence rate in patients with otolith dysfunction